Global Amlodipine Besylate Market Research Report 2024

Global Amlodipine Besylate Market Research Report 2024

Table of Contents
1 Amlodipine Besylate Market Overview
1.1 Product Overview and Scope of Amlodipine Besylate
1.2 Amlodipine Besylate Segment by Type
1.2.1 Global Amlodipine Besylate Market Value Comparison by Type (2024-2030)
1.2.2 2.5mg Tablets
1.2.3 5mg Tablets
1.2.4 10mg Tablets
1.3 Amlodipine Besylate Segment by Application
1.3.1 Global Amlodipine Besylate Market Value by Application: (2024-2030)
1.3.2 High Blood Pressure
1.3.3 Heart Disease
1.4 Global Amlodipine Besylate Market Size Estimates and Forecasts
1.4.1 Global Amlodipine Besylate Revenue 2019-2030
1.4.2 Global Amlodipine Besylate Sales 2019-2030
1.4.3 Global Amlodipine Besylate Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Amlodipine Besylate Market Competition by Manufacturers
2.1 Global Amlodipine Besylate Sales Market Share by Manufacturers (2019-2024)
2.2 Global Amlodipine Besylate Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Amlodipine Besylate Average Price by Manufacturers (2019-2024)
2.4 Global Amlodipine Besylate Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Amlodipine Besylate, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Amlodipine Besylate, Product Type & Application
2.7 Amlodipine Besylate Market Competitive Situation and Trends
2.7.1 Amlodipine Besylate Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Amlodipine Besylate Players Market Share by Revenue
2.7.3 Global Amlodipine Besylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Amlodipine Besylate Retrospective Market Scenario by Region
3.1 Global Amlodipine Besylate Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Amlodipine Besylate Global Amlodipine Besylate Sales by Region: 2019-2030
3.2.1 Global Amlodipine Besylate Sales by Region: 2019-2024
3.2.2 Global Amlodipine Besylate Sales by Region: 2025-2030
3.3 Global Amlodipine Besylate Global Amlodipine Besylate Revenue by Region: 2019-2030
3.3.1 Global Amlodipine Besylate Revenue by Region: 2019-2024
3.3.2 Global Amlodipine Besylate Revenue by Region: 2025-2030
3.4 North America Amlodipine Besylate Market Facts & Figures by Country
3.4.1 North America Amlodipine Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Amlodipine Besylate Sales by Country (2019-2030)
3.4.3 North America Amlodipine Besylate Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Amlodipine Besylate Market Facts & Figures by Country
3.5.1 Europe Amlodipine Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Amlodipine Besylate Sales by Country (2019-2030)
3.5.3 Europe Amlodipine Besylate Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Amlodipine Besylate Market Facts & Figures by Country
3.6.1 Asia Pacific Amlodipine Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Amlodipine Besylate Sales by Country (2019-2030)
3.6.3 Asia Pacific Amlodipine Besylate Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Amlodipine Besylate Market Facts & Figures by Country
3.7.1 Latin America Amlodipine Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Amlodipine Besylate Sales by Country (2019-2030)
3.7.3 Latin America Amlodipine Besylate Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Amlodipine Besylate Market Facts & Figures by Country
3.8.1 Middle East and Africa Amlodipine Besylate Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Amlodipine Besylate Sales by Country (2019-2030)
3.8.3 Middle East and Africa Amlodipine Besylate Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Amlodipine Besylate Sales by Type (2019-2030)
4.1.1 Global Amlodipine Besylate Sales by Type (2019-2024)
4.1.2 Global Amlodipine Besylate Sales by Type (2025-2030)
4.1.3 Global Amlodipine Besylate Sales Market Share by Type (2019-2030)
4.2 Global Amlodipine Besylate Revenue by Type (2019-2030)
4.2.1 Global Amlodipine Besylate Revenue by Type (2019-2024)
4.2.2 Global Amlodipine Besylate Revenue by Type (2025-2030)
4.2.3 Global Amlodipine Besylate Revenue Market Share by Type (2019-2030)
4.3 Global Amlodipine Besylate Price by Type (2019-2030)
5 Segment by Application
5.1 Global Amlodipine Besylate Sales by Application (2019-2030)
5.1.1 Global Amlodipine Besylate Sales by Application (2019-2024)
5.1.2 Global Amlodipine Besylate Sales by Application (2025-2030)
5.1.3 Global Amlodipine Besylate Sales Market Share by Application (2019-2030)
5.2 Global Amlodipine Besylate Revenue by Application (2019-2030)
5.2.1 Global Amlodipine Besylate Revenue by Application (2019-2024)
5.2.2 Global Amlodipine Besylate Revenue by Application (2025-2030)
5.2.3 Global Amlodipine Besylate Revenue Market Share by Application (2019-2030)
5.3 Global Amlodipine Besylate Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Amlodipine Besylate Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Mylan
6.2.1 Mylan Corporation Information
6.2.2 Mylan Description and Business Overview
6.2.3 Mylan Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Mylan Amlodipine Besylate Product Portfolio
6.2.5 Mylan Recent Developments/Updates
6.3 Dr. Reddy's Laboratories
6.3.1 Dr. Reddy's Laboratories Corporation Information
6.3.2 Dr. Reddy's Laboratories Description and Business Overview
6.3.3 Dr. Reddy's Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Dr. Reddy's Laboratories Amlodipine Besylate Product Portfolio
6.3.5 Dr. Reddy's Laboratories Recent Developments/Updates
6.4 Apotex
6.4.1 Apotex Corporation Information
6.4.2 Apotex Description and Business Overview
6.4.3 Apotex Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Apotex Amlodipine Besylate Product Portfolio
6.4.5 Apotex Recent Developments/Updates
6.5 Teva Pharmaceutical
6.5.1 Teva Pharmaceutical Corporation Information
6.5.2 Teva Pharmaceutical Description and Business Overview
6.5.3 Teva Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Teva Pharmaceutical Amlodipine Besylate Product Portfolio
6.5.5 Teva Pharmaceutical Recent Developments/Updates
6.6 Cipla
6.6.1 Cipla Corporation Information
6.6.2 Cipla Description and Business Overview
6.6.3 Cipla Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Cipla Amlodipine Besylate Product Portfolio
6.6.5 Cipla Recent Developments/Updates
6.7 Hikma Pharmaceuticals
6.6.1 Hikma Pharmaceuticals Corporation Information
6.6.2 Hikma Pharmaceuticals Description and Business Overview
6.6.3 Hikma Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Hikma Pharmaceuticals Amlodipine Besylate Product Portfolio
6.7.5 Hikma Pharmaceuticals Recent Developments/Updates
6.8 Strides Pharma
6.8.1 Strides Pharma Corporation Information
6.8.2 Strides Pharma Description and Business Overview
6.8.3 Strides Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Strides Pharma Amlodipine Besylate Product Portfolio
6.8.5 Strides Pharma Recent Developments/Updates
6.9 Upsher-Smith Laboratories
6.9.1 Upsher-Smith Laboratories Corporation Information
6.9.2 Upsher-Smith Laboratories Description and Business Overview
6.9.3 Upsher-Smith Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Upsher-Smith Laboratories Amlodipine Besylate Product Portfolio
6.9.5 Upsher-Smith Laboratories Recent Developments/Updates
6.10 InvaGen Pharmaceuticals
6.10.1 InvaGen Pharmaceuticals Corporation Information
6.10.2 InvaGen Pharmaceuticals Description and Business Overview
6.10.3 InvaGen Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.10.4 InvaGen Pharmaceuticals Amlodipine Besylate Product Portfolio
6.10.5 InvaGen Pharmaceuticals Recent Developments/Updates
6.11 Sun Pharmaceutical
6.11.1 Sun Pharmaceutical Corporation Information
6.11.2 Sun Pharmaceutical Amlodipine Besylate Description and Business Overview
6.11.3 Sun Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sun Pharmaceutical Amlodipine Besylate Product Portfolio
6.11.5 Sun Pharmaceutical Recent Developments/Updates
6.12 Aurobindo Pharma
6.12.1 Aurobindo Pharma Corporation Information
6.12.2 Aurobindo Pharma Amlodipine Besylate Description and Business Overview
6.12.3 Aurobindo Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Aurobindo Pharma Amlodipine Besylate Product Portfolio
6.12.5 Aurobindo Pharma Recent Developments/Updates
6.13 Lupin Pharmaceuticals
6.13.1 Lupin Pharmaceuticals Corporation Information
6.13.2 Lupin Pharmaceuticals Amlodipine Besylate Description and Business Overview
6.13.3 Lupin Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Lupin Pharmaceuticals Amlodipine Besylate Product Portfolio
6.13.5 Lupin Pharmaceuticals Recent Developments/Updates
6.14 Zydus Pharmaceuticals
6.14.1 Zydus Pharmaceuticals Corporation Information
6.14.2 Zydus Pharmaceuticals Amlodipine Besylate Description and Business Overview
6.14.3 Zydus Pharmaceuticals Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Zydus Pharmaceuticals Amlodipine Besylate Product Portfolio
6.14.5 Zydus Pharmaceuticals Recent Developments/Updates
6.15 Oxford Pharm
6.15.1 Oxford Pharm Corporation Information
6.15.2 Oxford Pharm Amlodipine Besylate Description and Business Overview
6.15.3 Oxford Pharm Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Oxford Pharm Amlodipine Besylate Product Portfolio
6.15.5 Oxford Pharm Recent Developments/Updates
6.16 Wockhardt
6.16.1 Wockhardt Corporation Information
6.16.2 Wockhardt Amlodipine Besylate Description and Business Overview
6.16.3 Wockhardt Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Wockhardt Amlodipine Besylate Product Portfolio
6.16.5 Wockhardt Recent Developments/Updates
6.17 Epic Pharma
6.17.1 Epic Pharma Corporation Information
6.17.2 Epic Pharma Amlodipine Besylate Description and Business Overview
6.17.3 Epic Pharma Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Epic Pharma Amlodipine Besylate Product Portfolio
6.17.5 Epic Pharma Recent Developments/Updates
6.18 CR Pharmaceutical
6.18.1 CR Pharmaceutical Corporation Information
6.18.2 CR Pharmaceutical Amlodipine Besylate Description and Business Overview
6.18.3 CR Pharmaceutical Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.18.4 CR Pharmaceutical Amlodipine Besylate Product Portfolio
6.18.5 CR Pharmaceutical Recent Developments/Updates
6.19 Alkem Laboratories
6.19.1 Alkem Laboratories Corporation Information
6.19.2 Alkem Laboratories Amlodipine Besylate Description and Business Overview
6.19.3 Alkem Laboratories Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.19.4 Alkem Laboratories Amlodipine Besylate Product Portfolio
6.19.5 Alkem Laboratories Recent Developments/Updates
6.20 MACLEODS
6.20.1 MACLEODS Corporation Information
6.20.2 MACLEODS Amlodipine Besylate Description and Business Overview
6.20.3 MACLEODS Amlodipine Besylate Sales, Revenue and Gross Margin (2019-2024)
6.20.4 MACLEODS Amlodipine Besylate Product Portfolio
6.20.5 MACLEODS Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Amlodipine Besylate Industry Chain Analysis
7.2 Amlodipine Besylate Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Amlodipine Besylate Production Mode & Process
7.4 Amlodipine Besylate Sales and Marketing
7.4.1 Amlodipine Besylate Sales Channels
7.4.2 Amlodipine Besylate Distributors
7.5 Amlodipine Besylate Customers
8 Amlodipine Besylate Market Dynamics
8.1 Amlodipine Besylate Industry Trends
8.2 Amlodipine Besylate Market Drivers
8.3 Amlodipine Besylate Market Challenges
8.4 Amlodipine Besylate Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Amlodipine Besylate Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Amlodipine Besylate Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Amlodipine Besylate Market Competitive Situation by Manufacturers in 2023
Table 4. Global Amlodipine Besylate Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Amlodipine Besylate Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Amlodipine Besylate Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Amlodipine Besylate Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Amlodipine Besylate Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Amlodipine Besylate, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Amlodipine Besylate, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Amlodipine Besylate, Product Type & Application
Table 12. Global Key Manufacturers of Amlodipine Besylate, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Amlodipine Besylate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amlodipine Besylate as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Amlodipine Besylate Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Amlodipine Besylate Sales by Region (2019-2024) & (K Units)
Table 18. Global Amlodipine Besylate Sales Market Share by Region (2019-2024)
Table 19. Global Amlodipine Besylate Sales by Region (2025-2030) & (K Units)
Table 20. Global Amlodipine Besylate Sales Market Share by Region (2025-2030)
Table 21. Global Amlodipine Besylate Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Amlodipine Besylate Revenue Market Share by Region (2019-2024)
Table 23. Global Amlodipine Besylate Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Amlodipine Besylate Revenue Market Share by Region (2025-2030)
Table 25. North America Amlodipine Besylate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Amlodipine Besylate Sales by Country (2019-2024) & (K Units)
Table 27. North America Amlodipine Besylate Sales by Country (2025-2030) & (K Units)
Table 28. North America Amlodipine Besylate Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Amlodipine Besylate Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Amlodipine Besylate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Amlodipine Besylate Sales by Country (2019-2024) & (K Units)
Table 32. Europe Amlodipine Besylate Sales by Country (2025-2030) & (K Units)
Table 33. Europe Amlodipine Besylate Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Amlodipine Besylate Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Amlodipine Besylate Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Amlodipine Besylate Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Amlodipine Besylate Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Amlodipine Besylate Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Amlodipine Besylate Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Amlodipine Besylate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Amlodipine Besylate Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Amlodipine Besylate Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Amlodipine Besylate Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Amlodipine Besylate Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Amlodipine Besylate Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Amlodipine Besylate Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Amlodipine Besylate Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Amlodipine Besylate Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Amlodipine Besylate Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Amlodipine Besylate Sales (K Units) by Type (2019-2024)
Table 51. Global Amlodipine Besylate Sales (K Units) by Type (2025-2030)
Table 52. Global Amlodipine Besylate Sales Market Share by Type (2019-2024)
Table 53. Global Amlodipine Besylate Sales Market Share by Type (2025-2030)
Table 54. Global Amlodipine Besylate Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Amlodipine Besylate Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Amlodipine Besylate Revenue Market Share by Type (2019-2024)
Table 57. Global Amlodipine Besylate Revenue Market Share by Type (2025-2030)
Table 58. Global Amlodipine Besylate Price (USD/Unit) by Type (2019-2024)
Table 59. Global Amlodipine Besylate Price (USD/Unit) by Type (2025-2030)
Table 60. Global Amlodipine Besylate Sales (K Units) by Application (2019-2024)
Table 61. Global Amlodipine Besylate Sales (K Units) by Application (2025-2030)
Table 62. Global Amlodipine Besylate Sales Market Share by Application (2019-2024)
Table 63. Global Amlodipine Besylate Sales Market Share by Application (2025-2030)
Table 64. Global Amlodipine Besylate Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Amlodipine Besylate Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Amlodipine Besylate Revenue Market Share by Application (2019-2024)
Table 67. Global Amlodipine Besylate Revenue Market Share by Application (2025-2030)
Table 68. Global Amlodipine Besylate Price (USD/Unit) by Application (2019-2024)
Table 69. Global Amlodipine Besylate Price (USD/Unit) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Amlodipine Besylate Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Mylan Corporation Information
Table 76. Mylan Description and Business Overview
Table 77. Mylan Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Mylan Amlodipine Besylate Product
Table 79. Mylan Recent Developments/Updates
Table 80. Dr. Reddy's Laboratories Corporation Information
Table 81. Dr. Reddy's Laboratories Description and Business Overview
Table 82. Dr. Reddy's Laboratories Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Dr. Reddy's Laboratories Amlodipine Besylate Product
Table 84. Dr. Reddy's Laboratories Recent Developments/Updates
Table 85. Apotex Corporation Information
Table 86. Apotex Description and Business Overview
Table 87. Apotex Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Apotex Amlodipine Besylate Product
Table 89. Apotex Recent Developments/Updates
Table 90. Teva Pharmaceutical Corporation Information
Table 91. Teva Pharmaceutical Description and Business Overview
Table 92. Teva Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Teva Pharmaceutical Amlodipine Besylate Product
Table 94. Teva Pharmaceutical Recent Developments/Updates
Table 95. Cipla Corporation Information
Table 96. Cipla Description and Business Overview
Table 97. Cipla Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Cipla Amlodipine Besylate Product
Table 99. Cipla Recent Developments/Updates
Table 100. Hikma Pharmaceuticals Corporation Information
Table 101. Hikma Pharmaceuticals Description and Business Overview
Table 102. Hikma Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. Hikma Pharmaceuticals Amlodipine Besylate Product
Table 104. Hikma Pharmaceuticals Recent Developments/Updates
Table 105. Strides Pharma Corporation Information
Table 106. Strides Pharma Description and Business Overview
Table 107. Strides Pharma Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Strides Pharma Amlodipine Besylate Product
Table 109. Strides Pharma Recent Developments/Updates
Table 110. Upsher-Smith Laboratories Corporation Information
Table 111. Upsher-Smith Laboratories Description and Business Overview
Table 112. Upsher-Smith Laboratories Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. Upsher-Smith Laboratories Amlodipine Besylate Product
Table 114. Upsher-Smith Laboratories Recent Developments/Updates
Table 115. InvaGen Pharmaceuticals Corporation Information
Table 116. InvaGen Pharmaceuticals Description and Business Overview
Table 117. InvaGen Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. InvaGen Pharmaceuticals Amlodipine Besylate Product
Table 119. InvaGen Pharmaceuticals Recent Developments/Updates
Table 120. Sun Pharmaceutical Corporation Information
Table 121. Sun Pharmaceutical Description and Business Overview
Table 122. Sun Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 123. Sun Pharmaceutical Amlodipine Besylate Product
Table 124. Sun Pharmaceutical Recent Developments/Updates
Table 125. Aurobindo Pharma Corporation Information
Table 126. Aurobindo Pharma Description and Business Overview
Table 127. Aurobindo Pharma Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 128. Aurobindo Pharma Amlodipine Besylate Product
Table 129. Aurobindo Pharma Recent Developments/Updates
Table 130. Lupin Pharmaceuticals Corporation Information
Table 131. Lupin Pharmaceuticals Description and Business Overview
Table 132. Lupin Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 133. Lupin Pharmaceuticals Amlodipine Besylate Product
Table 134. Lupin Pharmaceuticals Recent Developments/Updates
Table 135. Zydus Pharmaceuticals Corporation Information
Table 136. Zydus Pharmaceuticals Description and Business Overview
Table 137. Zydus Pharmaceuticals Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 138. Zydus Pharmaceuticals Amlodipine Besylate Product
Table 139. Zydus Pharmaceuticals Recent Developments/Updates
Table 140. Oxford Pharm Corporation Information
Table 141. Oxford Pharm Description and Business Overview
Table 142. Oxford Pharm Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 143. Oxford Pharm Amlodipine Besylate Product
Table 144. Oxford Pharm Recent Developments/Updates
Table 145. Wockhardt Corporation Information
Table 146. Wockhardt Description and Business Overview
Table 147. Wockhardt Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 148. Wockhardt Amlodipine Besylate Product
Table 149. Wockhardt Recent Developments/Updates
Table 150. Epic Pharma Corporation Information
Table 151. Epic Pharma Description and Business Overview
Table 152. Epic Pharma Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 153. Epic Pharma Amlodipine Besylate Product
Table 154. Epic Pharma Recent Developments/Updates
Table 155. CR Pharmaceutical Corporation Information
Table 156. CR Pharmaceutical Description and Business Overview
Table 157. CR Pharmaceutical Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 158. CR Pharmaceutical Amlodipine Besylate Product
Table 159. CR Pharmaceutical Recent Developments/Updates
Table 160. Alkem Laboratories Corporation Information
Table 161. Alkem Laboratories Description and Business Overview
Table 162. Alkem Laboratories Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 163. Alkem Laboratories Amlodipine Besylate Product
Table 164. Alkem Laboratories Recent Developments/Updates
Table 165. MACLEODS Corporation Information
Table 166. MACLEODS Description and Business Overview
Table 167. MACLEODS Amlodipine Besylate Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 168. MACLEODS Amlodipine Besylate Product
Table 169. MACLEODS Recent Developments/Updates
Table 170. Key Raw Materials Lists
Table 171. Raw Materials Key Suppliers Lists
Table 172. Amlodipine Besylate Distributors List
Table 173. Amlodipine Besylate Customers List
Table 174. Amlodipine Besylate Market Trends
Table 175. Amlodipine Besylate Market Drivers
Table 176. Amlodipine Besylate Market Challenges
Table 177. Amlodipine Besylate Market Restraints
Table 178. Research Programs/Design for This Report
Table 179. Key Data Information from Secondary Sources
Table 180. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Amlodipine Besylate
Figure 2. Global Amlodipine Besylate Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Amlodipine Besylate Market Share by Type in 2023 & 2030
Figure 4. 2.5mg Tablets Product Picture
Figure 5. 5mg Tablets Product Picture
Figure 6. 10mg Tablets Product Picture
Figure 7. Global Amlodipine Besylate Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Amlodipine Besylate Market Share by Application in 2023 & 2030
Figure 9. High Blood Pressure
Figure 10. Heart Disease
Figure 11. Global Amlodipine Besylate Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Amlodipine Besylate Market Size (2019-2030) & (US$ Million)
Figure 13. Global Amlodipine Besylate Sales (2019-2030) & (K Units)
Figure 14. Global Amlodipine Besylate Average Price (USD/Unit) & (2019-2030)
Figure 15. Amlodipine Besylate Report Years Considered
Figure 16. Amlodipine Besylate Sales Share by Manufacturers in 2023
Figure 17. Global Amlodipine Besylate Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Amlodipine Besylate Players: Market Share by Revenue in 2023
Figure 19. Amlodipine Besylate Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Amlodipine Besylate Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Amlodipine Besylate Sales Market Share by Country (2019-2030)
Figure 22. North America Amlodipine Besylate Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Amlodipine Besylate Sales Market Share by Country (2019-2030)
Figure 26. Europe Amlodipine Besylate Revenue Market Share by Country (2019-2030)
Figure 27. Germany Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Amlodipine Besylate Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Amlodipine Besylate Revenue Market Share by Region (2019-2030)
Figure 34. China Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Amlodipine Besylate Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Amlodipine Besylate Sales Market Share by Country (2019-203

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Pulmonary Arterial Hypertension (Pah) Medicine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Pulmonary Arterial Hypertension (Pah) Medicine market: According to our latest research, the global Pulmonary Arterial Hypertension (Pah) Medicine market looks promising in the next 5 years. As of 2022, the global Pulmonary Arterial Hypertension (Pah) Medicine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to ......

Global Nifedipine Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 04-Jan-2024        Price: US 3380 Onwards        Pages: 102

Market Overview of Global Nifedipine market: According to our latest research, the global Nifedipine market looks promising in the next 5 years. As of 2022, the global Nifedipine market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global Nifedipine market, with a systematical de......

Global Amlodipine Besylate Market Research Report 2024

Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 115

The Amlodipine Besylate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Amlodipine Besylate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profil......

Pulmonary Arterial Hypertension (PAH) Drugs - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 112

The global Pulmonary Arterial Hypertension (PAH) Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Pulmonary Arterial Hypertension (PAH) Drugs in various end use industries. The expanding demands from the Hospitals, Clinics and Other,, are propelling Pulmonary Arterial Hypertension (PAH) Drugs market. Inhalation, one of the segments analysed in this report, is projected to record % ......

Captopril API - Global Market Insights and Sales Trends 2024

Published: 25-Dec-2023        Price: US 3350 Onwards        Pages: 100

The global Captopril API market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Captopril API in various end use industries. The expanding demands from the Captopril Tablet, Compound Captopril Tablet and Captopril Injection,, are propelling Captopril API market. 98% Captopril API, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the......

Telmisartan - Global Market Insights and Sales Trends 2024

Published: 21-Dec-2023        Price: US 3350 Onwards        Pages: 107

The global Telmisartan market size is expected to reach US$ 3631.3 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the significant applications of Telmisartan in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Telmisartan market. Injection, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Freeze-Dried......

Global Ambrisentan Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 106

Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......

Global Ambrisentan Market Research Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 2680 Onwards        Pages: 132

Ambrisentan is a drug indicated for use in the treatment of pulmonary hypertension. The peptide endothelin constricts muscles in blood vessels, increasing blood pressure. Ambrisentan, which relaxes those muscles, is an endothelin receptor antagonist, and is selective for the type A endothelin receptor. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million US......

Global Amlodipine Besylate Professional Survey Report 2023, Forecast to 2028

Published: 20-Dec-2023        Price: US 3280 Onwards        Pages: 133

Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs